======= NAA35 ======= == Gene Information == * **Official Symbol**: N/AA35 * **Official Name**: N-alpha-acetyltransferase 35, NatC auxiliary subunit * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=60560|60560]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5VZE5|Q5VZE5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NAA35&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NAA35|Open PubMed]] * **OMIM**: [[https://omim.org/entry/619438|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Auxillary component of the N-terminal acetyltransferase C (NatC) complex which catalyzes acetylation of N-terminal methionine residues. Involved in regulation of apoptosis and proliferation of smooth muscle cells. {ECO:0000269|PubMed:19398576}. |Mak10| |NatC complex| |smooth muscle cell proliferation| |N-terminal peptidyl-methionine acetylation| |peptide alpha-N-acetyltransferase activity| |peptidyl-methionine modification| |N-terminal protein amino acid acetylation| |muscle cell proliferation| |N-terminal protein amino acid modification| |polysome| |protein acetylation| |protein acylation| |protein maturation| |cell population proliferation| |peptidyl-amino acid modification| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |negative regulation of cell death| |regulation of apoptotic process| |regulation of programmed cell death| |regulation of cell death| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp415|Trichostatin-A 0.06μM R07 exp415]]|-1.82| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-1.7| |[[:results:exp139|Nicotinamide Riboside 100μM R03 exp139]]|1.82| |[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|2| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|2.32| ^Gene^Correlation^ |[[:human genes:l:lsmd1|LSMD1]]|0.498| |[[:human genes:h:hars|HARS]]|0.414| |[[:human genes:t:tle4|TLE4]]|0.411| |[[:human genes:b:btaf1|BTAF1]]|0.409| |[[:human genes:s:smarcd1|SMARCD1]]|0.401| Global Fraction of Cell Lines Where Essential: 158/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|6/28| |blood|4/28| |bone|2/26| |breast|10/33| |central nervous system|4/56| |cervix|2/4| |colorectal|7/17| |esophagus|2/13| |fibroblast|1/1| |gastric|2/16| |kidney|4/21| |liver|3/20| |lung|28/75| |lymphocyte|4/16| |ovary|4/26| |pancreas|5/24| |peripheral nervous system|5/16| |plasma cell|0/15| |prostate|1/1| |skin|4/24| |soft tissue|4/9| |thyroid|0/2| |upper aerodigestive|4/22| |urinary tract|5/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1528 * **Expression level (log2 read counts)**: 5.3 {{:chemogenomics:nalm6 dist.png?nolink |}}